Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis

DOI record: { "DOI": "10.1016/j.euroneuro.2022.10.004", "ISSN": [ "0924-977X" ], "URL": "http://dx.doi.org/10.1016/j.euroneuro.2022.10.004", "alternative-id": [ "S0924977X22008720" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis" }, { "label": "Journal Title", "name": "journaltitle", "value": "European Neuropsychopharmacology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.euroneuro.2022.10.004" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 The Authors. Published by Elsevier B.V." } ], "author": [ { "ORCID": "https://orcid.org/0000-0003-1785-7126", "affiliation": [], "authenticated-orcid": false, "family": "Fico", "given": "Giovanna", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0003-3927-4810", "affiliation": [], "authenticated-orcid": false, "family": "Isayeva", "given": "Ulker", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-2032-1181", "affiliation": [], "authenticated-orcid": false, "family": "De Prisco", "given": "Michele", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-5961-6032", "affiliation": [], "authenticated-orcid": false, "family": "Oliva", "given": "Vincenzo", "sequence": "additional" }, { "affiliation": [], "family": "Solè", "given": "Brisa", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4407-9454", "affiliation": [], "authenticated-orcid": false, "family": "Montejo", "given": "Laura", "sequence": "additional" }, { "affiliation": [], "family": "Grande", "given": "Iria", "sequence": "additional" }, { "affiliation": [], "family": "Arbelo", "given": "Nestor", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-3463-0866", "affiliation": [], "authenticated-orcid": false, "family": "Gomez-Ramiro", "given": "Marta", "sequence": "additional" }, { "affiliation": [], "family": "Pintor", "given": "Luis", "sequence": "additional" }, { "affiliation": [], "family": "Carpiniello", "given": "Bernardo", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4175-6413", "affiliation": [], "authenticated-orcid": false, "family": "Manchia", "given": "Mirko", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-0548-0053", "affiliation": [], "authenticated-orcid": false, "family": "Vieta", "given": "Eduard", "sequence": "additional" }, { "affiliation": [], "family": "Murru", "given": "Andrea", "sequence": "additional" } ], "container-title": "European Neuropsychopharmacology", "container-title-short": "European Neuropsychopharmacology", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 10, 20 ] ], "date-time": "2022-10-20T07:38:13Z", "timestamp": 1666251493000 }, "deposited": { "date-parts": [ [ 2024, 1, 29 ] ], "date-time": "2024-01-29T11:14:36Z", "timestamp": 1706526876000 }, "indexed": { "date-parts": [ [ 2025, 7, 20 ] ], "date-time": "2025-07-20T22:45:09Z", "timestamp": 1753051509883, "version": "3.40.5" }, "is-referenced-by-count": 19, "issued": { "date-parts": [ [ 2023, 1 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 1, 1 ] ], "date-time": "2023-01-01T00:00:00Z", "timestamp": 1672531200000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 11, 23 ] ], "date-time": "2022-11-23T00:00:00Z", "timestamp": 1669161600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0924977X22008720?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0924977X22008720?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "30-44", "prefix": "10.1016", "published": { "date-parts": [ [ 2023, 1 ] ] }, "published-print": { "date-parts": [ [ 2023, 1 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.euroneuro.2022.10.004_bib0001", "unstructured": "AHRQ Comparative Effectiveness Reviews - NCBI Bookshelf [WWW Document], n.d. URL https://www.ncbi.nlm.nih.gov/books/NBK42934/(accessed 12.17.21)." }, { "DOI": "10.1016/j.jad.2020.05.149", "article-title": "COVID-19 inpatients with psychiatric disorders: real-world clinical recommendations from an expert team in consultation-liaison psychiatry", "author": "Anmella", "doi-asserted-by": "crossref", "first-page": "1062", "journal-title": "J. Affect. Disord.", "key": "10.1016/j.euroneuro.2022.10.004_bib0002", "volume": "274", "year": "2020" }, { "DOI": "10.1016/j.ejpsy.2020.10.004", "article-title": "Are dopamine and serotonin involved in COVID-19 pathophysiology?", "author": "Attademo", "doi-asserted-by": "crossref", "first-page": "62", "journal-title": "Eur. J. Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0003", "volume": "35", "year": "2021" }, { "DOI": "10.1007/s00213-015-4044-5", "article-title": "Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?", "author": "Baumeister", "doi-asserted-by": "crossref", "first-page": "1575", "journal-title": "Psychopharmacology", "key": "10.1016/j.euroneuro.2022.10.004_bib0004", "volume": "233", "year": "2016" }, { "DOI": "10.1056/NEJMoa2007764", "article-title": "Remdesivir for the treatment of Covid-19 — final report", "author": "Beigel", "doi-asserted-by": "crossref", "first-page": "1813", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0005", "volume": "383", "year": "2020" }, { "DOI": "10.1001/jamasurg.2021.0522", "article-title": "MOOSE Reporting guidelines for meta-analyses of observational studies", "author": "Brooke", "doi-asserted-by": "crossref", "first-page": "787", "journal-title": "JAMA Surg.", "key": "10.1016/j.euroneuro.2022.10.004_bib0006", "volume": "156", "year": "2021" }, { "DOI": "10.3390/pharmaceutics13091400", "article-title": "Combination therapy with fluoxetine and the nucleoside analog GS-441524 exerts synergistic antiviral effects against different SARS-CoV-2 variants in vitro", "author": "Brunotte", "doi-asserted-by": "crossref", "journal-title": "Pharmaceutics", "key": "10.1016/j.euroneuro.2022.10.004_bib0007", "volume": "13", "year": "2021" }, { "DOI": "10.1002/prp2.231", "article-title": "Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine", "author": "Caiaffo", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Pharmacol. Res. Perspect.", "key": "10.1016/j.euroneuro.2022.10.004_bib0008", "volume": "4", "year": "2016" }, { "DOI": "10.1016/j.schres.2021.02.002", "article-title": "Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population", "author": "Canal-Rivero", "doi-asserted-by": "crossref", "first-page": "53", "journal-title": "Schizophr. Res.", "key": "10.1016/j.euroneuro.2022.10.004_bib0009", "volume": "229", "year": "2021" }, { "article-title": "Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study. The Lancet regional health", "author": "Carbonell", "journal-title": "Europe", "key": "10.1016/j.euroneuro.2022.10.004_bib0010", "volume": "11", "year": "2021" }, { "article-title": "Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells", "author": "Carpinteiro", "journal-title": "Cell Rep. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0011", "volume": "1", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2021.12131", "article-title": "Global incidence of neurological manifestations among patients hospitalized with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY consortium", "author": "Chou", "doi-asserted-by": "crossref", "journal-title": "JAMA Netw. Open", "key": "10.1016/j.euroneuro.2022.10.004_bib0012", "volume": "4", "year": "2021" }, { "article-title": "Analysis of the impact of antidepressants and other medications on COVID-19 infection risk in a chronic psychiatric in-patient cohort", "author": "Clelland", "journal-title": "BJPsych Open", "key": "10.1016/j.euroneuro.2022.10.004_bib0013", "volume": "8", "year": "2021" }, { "DOI": "10.1073/pnas.1720553115", "article-title": "Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration", "author": "Cloutier", "doi-asserted-by": "crossref", "first-page": "E1550", "journal-title": "Proc. Natl. Acad. Sci. U. S. A.", "key": "10.1016/j.euroneuro.2022.10.004_bib0014", "volume": "115", "year": "2018" }, { "DOI": "10.1016/j.biopha.2021.111437", "article-title": "Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection", "author": "Creeden", "doi-asserted-by": "crossref", "journal-title": "Biomed. Pharmacother.", "key": "10.1016/j.euroneuro.2022.10.004_bib0015", "volume": "138", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2021.40568", "article-title": "Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19", "author": "Denson", "doi-asserted-by": "crossref", "journal-title": "JAMA Netw. Open", "key": "10.1016/j.euroneuro.2022.10.004_bib0017", "volume": "4", "year": "2021" }, { "DOI": "10.1111/acps.13304", "article-title": "Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients", "author": "Diez-Quevedo", "doi-asserted-by": "crossref", "first-page": "526", "journal-title": "Acta Psychiatr. Scand.", "key": "10.1016/j.euroneuro.2022.10.004_bib0019", "volume": "143", "year": "2021" }, { "DOI": "10.1289/isee.2020.virtual.P-1151", "doi-asserted-by": "crossref", "key": "10.1016/j.euroneuro.2022.10.004_bib0020", "unstructured": "Eick, S.M., Goin, D.E., Chartres, N., Lam, J., Woodruff, T.J., 2020. Assessing risk of bias in human environmental epidemiology studies using three tools: different conclusions from different tools. doi:10.1186/s13643-020-01490-8." }, { "DOI": "10.1038/s41598-021-03898-1", "article-title": "The outcomes of patients with diabetes mellitus in The Philippine CORONA Study", "author": "Espiritu", "doi-asserted-by": "crossref", "first-page": "24436", "journal-title": "Sci. Rep.", "key": "10.1016/j.euroneuro.2022.10.004_bib0021", "volume": "11", "year": "2021" }, { "DOI": "10.1056/NEJMra2026131", "article-title": "Cytokine storm", "author": "Fajgenbaum", "doi-asserted-by": "crossref", "first-page": "2255", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0022", "volume": "383", "year": "2020" }, { "article-title": "Can SSRI/SNRI antidepressants decrease the “cytokine storm” in the course of COVID-19 pneumonia?", "author": "Fei", "journal-title": "Panminerva Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0023", "year": "2021" }, { "DOI": "10.1038/s41586-020-2286-9", "article-title": "A SARS-CoV-2 protein interaction map reveals targets for drug repurposing", "author": "Gordon", "doi-asserted-by": "crossref", "first-page": "459", "journal-title": "Nature", "key": "10.1016/j.euroneuro.2022.10.004_bib0025", "volume": "583", "year": "2020" }, { "DOI": "10.2139/ssrn.3605316", "doi-asserted-by": "crossref", "key": "10.1016/j.euroneuro.2022.10.004_bib0026", "unstructured": "Govind, R., Fonseca De Freitas, D., Pritchard, M., Hayes, R.D., Maccabe, J.H., 2021. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. doi:10.1192/bjp.2020.151." }, { "DOI": "10.1016/j.phrs.2021.105534", "article-title": "Associations between COVID-19 and 30-day thromboembolic events and mortality in  people with dementia receiving antipsychotic medications", "author": "Harrison", "doi-asserted-by": "crossref", "journal-title": "Pharmacol. Res.", "key": "10.1016/j.euroneuro.2022.10.004_bib0027", "volume": "167", "year": "2021" }, { "DOI": "10.2147/TCRM.S3470", "article-title": "Interleukin-6 inhibitors in the treatment of rheumatoid arthritis", "author": "Hennigan", "doi-asserted-by": "crossref", "first-page": "767", "journal-title": "Ther. Clin. Risk Manag.", "key": "10.1016/j.euroneuro.2022.10.004_bib0028", "volume": "4", "year": "2008" }, { "DOI": "10.1186/1471-2458-13-154", "article-title": "Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review", "author": "Herzog", "doi-asserted-by": "crossref", "first-page": "154", "journal-title": "BMC Public Health", "key": "10.1016/j.euroneuro.2022.10.004_bib0029", "volume": "13", "year": "2013" }, { "DOI": "10.1136/bmj.d5928", "article-title": "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", "author": "Higgins", "doi-asserted-by": "crossref", "journal-title": "BMJ", "key": "10.1016/j.euroneuro.2022.10.004_bib0030", "volume": "343", "year": "2011" }, { "DOI": "10.1038/s41380-021-01021-4", "article-title": "Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study", "author": "Hoertel", "doi-asserted-by": "crossref", "first-page": "5199", "journal-title": "Mol. Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0032", "volume": "26", "year": "2021" }, { "author": "Hoertel", "key": "10.1016/j.euroneuro.2022.10.004_bib0031", "series-title": "Observational study of haloperidol in hospitalized patients with COVID-19", "year": "2021" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "journal-title": "Cell", "key": "10.1016/j.euroneuro.2022.10.004_bib0034", "volume": "181", "year": "2020" }, { "DOI": "10.1016/j.bbrc.2020.08.116", "article-title": "RNA-dependent RNA polymerase: structure, mechanism, and drug discovery for COVID-19", "author": "Jiang", "doi-asserted-by": "crossref", "first-page": "47", "journal-title": "Biochem. Biophys. Res. Commun.", "key": "10.1016/j.euroneuro.2022.10.004_bib0035", "volume": "538", "year": "2021" }, { "DOI": "10.1016/j.ijpharm.2021.121023", "article-title": "Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection", "author": "Khater", "doi-asserted-by": "crossref", "journal-title": "Int. J. Pharm.", "key": "10.1016/j.euroneuro.2022.10.004_bib0036", "volume": "607", "year": "2021" }, { "DOI": "10.1001/jama.2020.22760", "article-title": "Fluvoxamine vs Placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial", "author": "Lenze", "doi-asserted-by": "crossref", "first-page": "2292", "journal-title": "JAMA", "key": "10.1016/j.euroneuro.2022.10.004_bib0038", "volume": "324", "year": "2020" }, { "DOI": "10.1016/j.eclinm.2021.101111", "article-title": "Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action", "author": "Liu", "doi-asserted-by": "crossref", "journal-title": "EClinicalMedicine", "key": "10.1016/j.euroneuro.2022.10.004_bib0040", "volume": "40", "year": "2021" }, { "article-title": "Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition", "author": "Liu", "journal-title": "medRxiv", "key": "10.1016/j.euroneuro.2022.10.004_bib0041", "year": "2021" }, { "DOI": "10.1016/j.euroneuro.2022.04.006", "article-title": "Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): recommendations for health care professionals” (Falconi A et al., 2022)", "author": "Llach", "doi-asserted-by": "crossref", "first-page": "56", "journal-title": "Eur. Neuropsychopharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0042", "volume": "59", "year": "2022" }, { "DOI": "10.1016/j.euroneuro.2021.04.019", "article-title": "Mind long COVID: psychiatric sequelae of SARS-CoV-2 infection", "author": "Llach", "doi-asserted-by": "crossref", "first-page": "119", "journal-title": "Eur. Neuropsychopharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0043", "volume": "49", "year": "2021" }, { "DOI": "10.1016/j.bioorg.2021.104862", "article-title": "Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay", "author": "Loschwitz", "doi-asserted-by": "crossref", "journal-title": "Bioorg. Chem.", "key": "10.1016/j.euroneuro.2022.10.004_bib0044", "volume": "111", "year": "2021" }, { "DOI": "10.1016/j.lfs.2020.118889", "article-title": "Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro", "author": "Lu", "doi-asserted-by": "crossref", "journal-title": "Life Sci.", "key": "10.1016/j.euroneuro.2022.10.004_bib0045", "volume": "266", "year": "2021" }, { "DOI": "10.1186/s12916-021-01907-8", "doi-asserted-by": "crossref", "key": "10.1016/j.euroneuro.2022.10.004_bib0047", "unstructured": "McKeigue, P.M., Kennedy, S., Weir, A., Bishop, J., McGurnaghan, S.J., McAllister, D., Robertson, C., Wood, R., Lone, N., Murray, J., Caparrotta, T.M., Smith-Palmer, A., Goldberg, D., McMenamin, J., Guthrie, B., Hutchinson, S., 2021. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. doi:10.1186/s12916-021-01907-8." }, { "DOI": "10.1016/j.bioorg.2020.104490", "article-title": "Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review", "author": "Mohamed", "doi-asserted-by": "crossref", "journal-title": "Bioorg. Chem.", "key": "10.1016/j.euroneuro.2022.10.004_bib0049", "volume": "106", "year": "2021" }, { "DOI": "10.1007/s00213-013-3383-3", "article-title": "Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics", "author": "Mondelli", "doi-asserted-by": "crossref", "first-page": "317", "journal-title": "Psychopharmacology", "key": "10.1016/j.euroneuro.2022.10.004_bib0050", "volume": "231", "year": "2013" }, { "DOI": "10.1186/s40345-020-00191-4", "article-title": "Lithium's antiviral effects: a potential drug for CoViD-19 disease?", "author": "Murru", "doi-asserted-by": "crossref", "journal-title": "Int. J. Bipolar Disord.", "key": "10.1016/j.euroneuro.2022.10.004_bib0051", "volume": "8", "year": "2020" }, { "DOI": "10.1177/2472555220975672", "article-title": "COMPARE analysis, a bioinformatic approach to accelerate drug repurposing against Covid-19 and other emerging epidemics", "author": "Naasani", "doi-asserted-by": "crossref", "first-page": "345", "journal-title": "SLAS Discov.", "key": "10.1016/j.euroneuro.2022.10.004_bib0052", "volume": "26", "year": "2021" }, { "DOI": "10.1001/jamapsychiatry.2021.2503", "article-title": "Association Between antipsychotic use and COVID-19 mortality among people with serious mental illness", "author": "Nemani", "doi-asserted-by": "crossref", "journal-title": "JAMA Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0053", "volume": "78", "year": "2021" }, { "article-title": "Clozapine treatment and risk of severe COVID-19 infection", "author": "Ohlis", "journal-title": "Acta Psychiatr. Scand.", "key": "10.1016/j.euroneuro.2022.10.004_bib0054", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2021.33090", "article-title": "Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants", "author": "Oskotsky", "doi-asserted-by": "crossref", "journal-title": "JAMA Netw. Open", "key": "10.1016/j.euroneuro.2022.10.004_bib0055", "volume": "4", "year": "2021" }, { "DOI": "10.1177/2045125320942703", "article-title": "Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches", "author": "Ostuzzi", "doi-asserted-by": "crossref", "journal-title": "Ther. Adv. Psychopharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0056", "volume": "10", "year": "2020" }, { "article-title": "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews", "author": "Page", "journal-title": "BMJ", "key": "10.1016/j.euroneuro.2022.10.004_bib0057", "volume": "372", "year": "2021" }, { "DOI": "10.1007/s00109-020-01980-1", "article-title": "Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis", "author": "Pandey", "doi-asserted-by": "crossref", "first-page": "1659", "journal-title": "J. Mol. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0058", "volume": "98", "year": "2020" }, { "DOI": "10.1038/s41598-018-21769-0", "article-title": "Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder", "author": "Pietruczuk", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Sci. Rep.", "key": "10.1016/j.euroneuro.2022.10.004_bib0059", "volume": "8", "year": "2018" }, { "DOI": "10.1016/S2215-0366(19)30416-X", "article-title": "Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis", "author": "Pillinger", "doi-asserted-by": "crossref", "first-page": "64", "journal-title": "Lancet Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0060", "volume": "7", "year": "2020" }, { "DOI": "10.1016/j.encep.2020.05.006", "article-title": "Repurposing chlorpromazine to treat COVID-19: the reCoVery study", "author": "Plaze", "doi-asserted-by": "crossref", "first-page": "169", "journal-title": "Encephale", "key": "10.1016/j.euroneuro.2022.10.004_bib0061", "volume": "46", "year": "2020" }, { "DOI": "10.3390/ijerph17145171", "article-title": "Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain", "author": "Poblador-Plou", "doi-asserted-by": "crossref", "journal-title": "Int. J. Environ. Res. Public Health", "key": "10.1016/j.euroneuro.2022.10.004_bib0062", "volume": "17", "year": "2020" }, { "DOI": "10.1056/NEJMoa2034577", "article-title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine", "author": "Polack", "doi-asserted-by": "crossref", "first-page": "2603", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0063", "volume": "383", "year": "2020" }, { "DOI": "10.1016/S2213-2600(20)30552-X", "article-title": "Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study", "author": "Pun", "doi-asserted-by": "crossref", "first-page": "239", "journal-title": "Lancet Respir. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0064", "volume": "9", "year": "2021" }, { "DOI": "10.1016/j.euroneuro.2021.09.001", "article-title": "Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review", "author": "Reininghaus", "doi-asserted-by": "crossref", "first-page": "90", "journal-title": "Eur. Neuropsychopharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0065", "volume": "54", "year": "2022" }, { "article-title": "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial", "author": "Reis", "journal-title": "Lancet Glob. Health", "key": "10.1016/j.euroneuro.2022.10.004_bib0066", "volume": "0", "year": "2021" }, { "DOI": "10.1126/scitranslmed.aau5266", "article-title": "Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis", "author": "Rosen", "doi-asserted-by": "crossref", "journal-title": "Sci. Transl. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0067", "volume": "11", "year": "2019" }, { "DOI": "10.1056/NEJMoa2030340", "article-title": "Tocilizumab in patients hospitalized with Covid-19 pneumonia", "author": "Salama", "doi-asserted-by": "crossref", "first-page": "20", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0068", "volume": "384", "year": "2020" }, { "DOI": "10.1080/22221751.2020.1829082", "article-title": "Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine", "author": "Schloer", "doi-asserted-by": "crossref", "first-page": "2245", "journal-title": "Emerg. Microbes Infect.", "key": "10.1016/j.euroneuro.2022.10.004_bib0069", "volume": "9", "year": "2020" }, { "DOI": "10.1111/bph.15418", "article-title": "Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro", "author": "Schloer", "doi-asserted-by": "crossref", "first-page": "2339", "journal-title": "Br. J. Pharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0070", "volume": "178", "year": "2021" }, { "DOI": "10.1038/s41467-019-13940-6", "article-title": "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV", "author": "Sheahan", "doi-asserted-by": "crossref", "first-page": "222", "journal-title": "Nat. Commun.", "key": "10.1016/j.euroneuro.2022.10.004_bib0071", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.crphar.2021.100072", "doi-asserted-by": "crossref", "key": "10.1016/j.euroneuro.2022.10.004_bib0072", "unstructured": "Smith, P.O., Jin, P., Rahman, K.M., 2021. Strategies for drug repurposing against coronavirus targets. Current research in pharmacology and drug discovery 100072. doi:10.1016/J.CRPHAR.2021.100072." }, { "DOI": "10.3389/fphar.2021.652688", "article-title": "Fluvoxamine: a review of its mechanism of action and its role in COVID-19", "author": "Sukhatme", "doi-asserted-by": "crossref", "journal-title": "Front. Pharmacol.", "key": "10.1016/j.euroneuro.2022.10.004_bib0073", "volume": "12", "year": "2021" }, { "DOI": "10.1016/j.jphotobiol.2020.111997", "article-title": "Laser irradiated phenothiazines: new potential treatment for COVID-19 explored by molecular docking", "author": "Udrea", "doi-asserted-by": "crossref", "journal-title": "J. Photochem. Photobiol. B", "key": "10.1016/j.euroneuro.2022.10.004_bib0074", "volume": "211", "year": "2020" }, { "DOI": "10.18632/aging.103449", "article-title": "Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?", "author": "Viel", "doi-asserted-by": "crossref", "first-page": "10035", "journal-title": "Aging", "key": "10.1016/j.euroneuro.2022.10.004_bib0075", "volume": "12", "year": "2020" }, { "DOI": "10.1002/wps.20806", "article-title": "Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "124", "journal-title": "World Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0076", "volume": "20", "year": "2021" }, { "key": "10.1016/j.euroneuro.2022.10.004_bib0077", "series-title": "WHO Official Updates - Coronavirus Disease 2019 [WWW Document]", "year": "2021" }, { "DOI": "10.2147/NDT.S123121", "article-title": "Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder", "author": "Yoshimura", "doi-asserted-by": "crossref", "first-page": "437", "journal-title": "Neuropsychiatr. Dis. Treat.", "key": "10.1016/j.euroneuro.2022.10.004_bib0078", "volume": "13", "year": "2017" }, { "DOI": "10.1111/jebm.12141", "article-title": "The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review", "author": "Zeng", "doi-asserted-by": "crossref", "first-page": "2", "journal-title": "J. Evid. Based Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0079", "volume": "8", "year": "2015" }, { "DOI": "10.1186/s12888-017-1539-0", "article-title": "The metabolic side effects of 12 antipsychotic drugs used for the treatment of Schizophrenia on glucose: a network meta-analysis", "author": "Zhang", "doi-asserted-by": "crossref", "journal-title": "BMC Psychiatry", "key": "10.1016/j.euroneuro.2022.10.004_bib0080", "volume": "17", "year": "2017" }, { "DOI": "10.1056/NEJMoa2001017", "article-title": "A novel coronavirus from patients with pneumonia in China, 2019", "author": "Zhu", "doi-asserted-by": "crossref", "first-page": "727", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.euroneuro.2022.10.004_bib0081", "volume": "382", "year": "2020" } ], "reference-count": 73, "references-count": 73, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924977X22008720" } }, "score": 1, "short-title": [], "source": "Crossref", "special_numbering": "C", "subject": [], "subtitle": [], "title": "Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "66" }